Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) Raised to Strong-Buy at Barclays

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) was upgraded by equities researchers at Barclays to a “strong-buy” rating in a research note issued on Tuesday,Zacks.com reports.

Several other equities analysts have also recently weighed in on MURGY. Jefferies Financial Group cut Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “buy” rating to a “hold” rating in a report on Monday, October 21st. UBS Group cut Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “strong-buy” rating to a “hold” rating in a report on Thursday, December 19th. Finally, Berenberg Bank cut Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a “strong-buy” rating to a “hold” rating in a report on Friday, October 25th.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Price Performance

OTCMKTS MURGY opened at $11.01 on Tuesday. The business’s fifty day moving average price is $10.41 and its 200-day moving average price is $10.36. The stock has a market capitalization of $73.63 billion, a price-to-earnings ratio of 7.16, a PEG ratio of 1.73 and a beta of 1.02. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.12 and a quick ratio of 1.12. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München has a 1-year low of $8.40 and a 1-year high of $11.20.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Company Profile

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.